Lördag 5 Juli | 11:43:44 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2020-11-20 - Extra Bolagsstämma
2015-12-09 - 15-6 2015
2015-09-21 - Extra Bolagsstämma 2015
2014-11-27 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-05-22 - Kvartalsrapport 2014-Q1
2014-02-27 - Bokslutskommuniké 2013
2013-11-28 - Kvartalsrapport 2013-Q3
2013-08-28 - Kvartalsrapport 2013-Q2
2013-06-11 - Årsstämma
2013-05-21 - Kvartalsrapport 2013-Q1
2013-03-12 - Extra Bolagsstämma 2013
2013-02-28 - Bokslutskommuniké 2012
2012-11-28 - Kvartalsrapport 2012-Q3
2012-08-28 - Kvartalsrapport 2012-Q2
2012-06-14 - Årsstämma
2012-05-30 - Kvartalsrapport 2012-Q1
2012-02-28 - Bokslutskommuniké 2011
2011-11-22 - Kvartalsrapport 2011-Q3
2011-08-31 - Kvartalsrapport 2011-Q2
2011-06-15 - Årsstämma
2011-05-31 - Kvartalsrapport 2011-Q1
2011-02-28 - Bokslutskommuniké 2010
2020-11-11 13:15:07
Reference is made to the notice published on NOTC on 6 November 2020 in which it was informed that ImmunoPharma has requested an extraordinary general meeting to resolve a 
de-listing of Eqology's shares from NOTC during December 2020.

The board of Eqology AS has resolved to comply with the request, and call for an extraordinary general meeting to be held on 20 November 2020 at 1 pm CET, at the company’s premises in Lilleakerveien 2B, 0283 Oslo.

Due to the current measures in force to contain the spread of Covid-19, shareholders are encouraged to refrain from attending in person, and instead participate electronically or by granting a proxy in advance.

The notice of the extraordinary general meeting is attached.

For questions, contact:

Roar Arnstad
CEO
E-mail: roar.arnstad@eqology.no

Christian Espeseth
Chairman of the board